Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Yiming Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the development and large-scale production of active pharmaceutical ingredients (APIs) and finished dosage forms. Established in 1993 and headquartered in Foshan, the company has grown into one of the world's leading manufacturers of Ribavirin, an essential antiviral agent. Their product portfolio spans several therapeutic areas, including anti-infectives, cardiovascular health, and digestive system treatments. The company maintains state-of-the-art, GMP-certified manufacturing facilities that ensure compliance with international quality standards. Guangdong Yiming serves a global clientele, exporting its chemical drugs and intermediates to numerous countries across Asia, Europe, and the Americas. Through continuous investment in R&D and process optimization, the firm remains a competitive force in the global generic pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangdong Yiming Pharmaceutical.